These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77. Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy. Wang S; Cheng M; Hu Z; Hu S; Zou Q; Lai X; Liu B; Jiang H; Huang C; Wu G Cell Physiol Biochem; 2017; 44(6):2281-2295. PubMed ID: 29262413 [TBL] [Abstract][Full Text] [Related]
78. Hypothetical pathways of cardiac myocyte hypertrophy: response to myocardial injury. Francis GS; Carlyle WC Eur Heart J; 1993 Nov; 14 Suppl J():49-56. PubMed ID: 8281963 [TBL] [Abstract][Full Text] [Related]
79. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis. Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543 [TBL] [Abstract][Full Text] [Related]
80. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling. Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]